Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
The Journal of General Physiology|March 8, 2019
Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac functionGizem Keceli, Ananya Majumdar, Chevon N Thorpe, et al.Breast Cancer Research and Treatment|September 28, 2011
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitorsCarmine Fedele, Gennaro Riccio, Carmela Coppola, et al.Current Molecular Medicine|December 8, 2004
The chemical dynamics of NO and reactive nitrogen oxides: a practical guideDaniele Mancardi, Lisa A Ridnour, Douglas D Thomas, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 17, 2016
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyNicola Maurea, Paolo Spallarossa, Christian Cadeddu, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 17, 2016
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyPaolo Spallarossa, Nicola Maurea, Christian Cadeddu, et al.Circulation Research|December 14, 2004
Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failureTatsuo Katori, Donald B Hoover, Jeffrey L Ardell, et al.Cardiovascular Research|February 5, 2019
Cardiovascular toxicities associated with immune checkpoint inhibitorsJiun-Ruey Hu, Roberta Florido, Evan J Lipson, et al.Cardiovascular Research|May 9, 2020
Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial functionMarisol Ruiz-Meana, Diana Bou-Teen, Péter Ferdinandy, et al.Circulation Research|December 17, 2005
Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathwayMarco Mongillo, Carlo G Tocchetti, Anna Terrin, et al.Cardiac Failure Review|June 11, 2019
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer PatientsAlessandra Cuomo, Alessio Rodolico, Amalia Galdieri, et al.Pageof 11